UNSPSC 51172166: Denaverine hydrochloride

This classification denotes an anticholinergic agent with the molecular formula C24H33NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AFK8FCD4R, chemically known as benzeneacetic acid, alpha-(2-ethylbutoxy)-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hcl but more generally known as denaverine hydrochloride, which bears US NIH Compound Identifier 18726. European Medicines Agency schedules Denaverine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01583MIG.

Most nations, for tariff and trade purposes, schedule denaverine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, DENAVERINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Denaverine hydrochloride bears US NLM NCI C97976. SMILES: CCC(CC)COC(C1CCCCC1)(C2CCCCC2)C(=O)OCCN(C)C.CL.

UNSPSC 51172166 Denaverine hydrochloride is a Commodity code that carries minimal relevance to the state and local procurement activity currently tagged under it. The single recent opportunity recorded under this code is Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services, which solicits laboratory testing infrastructure, staffing, and analytical methodology — not pharmaceutical products. The scope includes immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, electronic result reporting, and Interactive Voice Response notification systems. Collin County is requesting proposals for two collection sites in Plano and McKinney operating Monday through Friday with limited Saturday hours, supporting approximately 25,031 annual tests under a contract estimated at $600,000 over an initial two-year term with optional one-year renewals through year five. Successful vendors must hold lab certification from SAMHSA, Texas Department of Public Safety, or CAP and submit pricing on a per-test basis across three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives.

The code shows no meaningful geographic spread or pattern of recent activity across state and local jurisdictions — only the single Collin County solicitation appears in the record. The mismatch between the code's pharmaceutical label and the actual work being purchased (drug testing services and infrastructure) suggests this code may have been applied in error by the county procurement office or that denaverine hydrochloride is used tangentially in confirmatory testing protocols at a level too minor to reflect in the primary scope statement. Practitioners evaluating this code should treat it as inactive for general state and local procurement purposes and verify directly with issuing bodies whether any future pharmaceutical procurement is planned under this or related commodity codes.